UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases

Clinical cancer research, 2016-12, Vol.22 (24), p.6078-6087

2016

Volltextzugriff (PDF)

Tweety-Homolog 1 Drives Brain Colonization of Gliomas

The Journal of neuroscience, 2017-07, Vol.37 (29), p.6837-6850

2017

Volltextzugriff (PDF)

Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival

Cell stem cell, 2014-08, Vol.15 (2), p.185-198

2014

Volltextzugriff (PDF)

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (1), p.409-414

2014

Volltextzugriff (PDF)

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma

Molecular cancer research, 2018-05, Vol.16 (5), p.767-776

2018

Volltextzugriff (PDF)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma

Oncotarget, 2015-10, Vol.6 (31), p.31050-31068

2015

Volltextzugriff (PDF)

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy

Oncotarget, 2016-08, Vol.7 (35), p.56713-56725

2016

Volltextzugriff (PDF)

mTORC 2:1 for chemotherapy sensitization in glioblastoma

Cancer discovery, 2011-11, Vol.1 (6), p.475-476

2011

Volltextzugriff (PDF)

A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.189-199

2024

Volltextzugriff (PDF)

HLA-DQA105 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies

Journal of Crohn's and colitis, 2024-08

2024

Volltextzugriff (PDF)

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis

Clinical pharmacokinetics, 2023-04, Vol.62 (4), p.623-634

2023

Volltextzugriff (PDF)

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway

Glia, 2015-01, Vol.63 (1), p.78-90

2015

Volltextzugriff (PDF)

HLA-DQA105 associates with anti-TNF immunogenicity and low adalimumab trough concentrations in inflammatory bowel disease patients from the SERENE UC and CD studies

Journal of Crohn's and colitis, 2024-08

2024

Volltextzugriff (PDF)

NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment

Cancer letters, 2016-10, Vol.380 (2), p.568-576

2016

Volltextzugriff (PDF)

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum

Bioanalysis, 2021-04, Vol.13 (7), p.537-549

2021

Volltextzugriff (PDF)

Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?

Journal of neurochemistry, 2014-10, Vol.131 (2), p.251-264

2014

Volltextzugriff (PDF)

Effect of Glioma N-Myc downstream regulated gene 1 (NDRG1) on the tumor microenvironment

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11587-11587

2016

Volltextzugriff (PDF)

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway: FKBP52 Regulates TDO in Glioblastoma

Glia, 2015-01, Vol.63 (1), p.78-90

2015

Volltextzugriff (PDF)

Abstract 4736: N-myc downstream regulated gene 1: A novel mediator of hypoxia-driven chemoresistance in glioblastoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4736-4736

2012

Volltextzugriff (PDF)

Versatile Skill Control via Self-supervised Adversarial Imitation of Unlabeled Mixed Motions

2023 IEEE International Conference on Robotics and Automation (ICRA), 2023, p.2944-2950

2023

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)
Tagungsberichte
(1)

Sprache

Englisch
(22)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Humans
(15)
Life Sciences & Biomedicine
(14)
Animals
(11)
Mice
(10)
Cell Line, Tumor
(7)
Mice, Nude
(7)
Oncology
(7)
Brain Neoplasms - Pathology
(6)
Brain Neoplasms - Metabolism
(5)
Cell Biology
(5)
Glioblastoma
(5)
Tumors
(5)
Brain Neoplasms - Drug Therapy
(4)
Gene Expression Regulation, Neoplastic
(4)
Glioblastoma - Metabolism
(4)
Glioma - Metabolism
(4)
Glioma - Pathology
(4)
Time Factors
(4)
Brain Neoplasms - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases

Tweety-Homolog 1 Drives Brain Colonization of Gliomas

Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival

mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy

mTORC 2:1 for chemotherapy sensitization in glioblastoma

A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants

Brain tumour cells interconnect to a functional and resistant network

HLA-DQA105 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway

HLA-DQA105 associates with anti-TNF immunogenicity and low adalimumab trough concentrations in inflammatory bowel disease patients from the SERENE UC and CD studies

NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum

Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?

Effect of Glioma N-Myc downstream regulated gene 1 (NDRG1) on the tumor microenvironment

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway: FKBP52 Regulates TDO in Glioblastoma

Abstract 4736: N-myc downstream regulated gene 1: A novel mediator of hypoxia-driven chemoresistance in glioblastoma

Versatile Skill Control via Self-supervised Adversarial Imitation of Unlabeled Mixed Motions

Suchergebnisse filtern